摘要
目的探讨阿奇霉素联合克拉霉素分散片治疗小儿支原体肺炎的临床疗效与安全性。方法方便选择该院2014年1月—2015年1月收治的90例支原体肺炎患儿为研究对象,随机分成观察组和对照组,对照组采用阿奇霉素治疗,观察组给予阿奇霉素联合克拉霉素治疗,比较两组患儿的临床疗效、主要临床症状体征消失时间。结果观察组总有效率为97.8%,显著高于对照组总有效率为86.7%(P<0.05);观察组主要临床症状体征的消失时间均显著低于对照组(P<0.05)。结论应用阿奇霉素联合克拉霉素治疗小儿支原体肺炎,能够显著改善患儿的临床症状,缩短患儿住院时间,值得临床推广应用。
Objective To investigate the azithromycin and clarithromycin dispersible tablets in the treatment of children with mycoplasma pneumonia clinical efficacy and safety. Methods Convenient choose in recent years in our hospital from January 2014 to 2015- January 90 cases of mycoplasma pneumonia in children as the research object and randomly divided into observation group and control group, the control group was treated with azithromycin in the treatment, the observation group given azithromycin and clarithromycin in the treatment, the clinical efficacy of patients were compared between the two groups, the main clinical symptoms and signs disappeared time. Results The total effective rate of observation group was 97.8%, the total efficiency of the control group was significantly higher than that of 86.7%（P〈0.05）; the disappearance time of the observation group the clinical signs and symptoms were significantly lower than the control group（P〈0.05）. Conclusion Application of clarithromycin and azithromycin treatment of mycoplasma pneumonia in children, can significantly improve the patient＇s clinical symptoms, shorten the time of hospitalization, it is worth of clinical application.
出处
《中外医疗》
2016年第16期120-121,共2页
China & Foreign Medical Treatment
关键词
小儿支原体肺炎
阿奇霉素
安全性
Children Mycoplasma pneumonia
Azithromycin
Security
